YSS

YSS - York Space Systems Inc

OPPORTUNISTIC BUYIN BUY ZONETechnology - Communication EquipmentAnalysis generated 2026-10-04Market data as of 2026-11-12Market data 3 days oldUSD 6.60
59
Conviction
out of 100

Executive Summary

York Space Systems Inc (YSS) is a US-based small-satellite and mission prime contractor that designs, manufactures, and operates spacecraft and related hardware principally for US national-security and civil-space customers. The company holds an emerging position in the proliferated low-Earth-orbit (PLEO) segment, where it is one of a handful of domestic suppliers cleared to deliver full mission solutions rather than individual bus or payload components. Operations are headquartered in Colorado and revenue is reported in US dollars.

The investment case rests on continued conversion of the US Department of Defense's proliferated-architecture procurement pipeline into booked backlog, with the Q4 2025 earnings release (already reported on 15 April 2026) and the next scheduled disclosure of FY26 progress the principal near-term checkpoints. To work, management must execute against the recently disclosed 2026 revenue guide without further downward revision, and absorb the Solestial acquisition without margin dilution beyond the current negative band. The primary risk is that the filing-disclosed warning of sustained unprofitability crystallises before backlog converts to cash earnings, capping any re-rating despite the headline contract momentum.

OPPORTUNISTIC BUY. Conviction Score: 59/100. A clean beat of 2026 revenue guidance accompanied by a credible margin recovery plan would lift the score toward the 70s; a second consecutive guidance cut or a missed US Space Force milestone would push it below 45.

Buy zone. Current price USD 6.60 is at or below the buy ceiling of USD 7.33. New positions are justified by the model.
IN BUY ZONEOPPORTUNISTIC BUY · 59/100Now USD 6.60 · buy ≤ USD 7.33 · trim ≥ USD 11.00

Thesis break: A second consecutive reduction to 2026 revenue guidance, a named loss of the NITE-STAR programme or another flagship mission-prime contract, or confirmation of a dilutive equity raise to fund operations.

Business Model

Revenue is generated through fixed-price and cost-plus contracts for the design, manufacture, integration, launch support, and on-orbit operation of small satellites and complete space-vehicle missions. The customer base is heavily concentrated in the US public sector, principally the Department of Defense, the Space Development Agency, and the Missile Defense Agency, with smaller contributions from intelligence community primes acting as subcontractors and from civil-space programmes. Underlying research cites full-year 2025 revenue of approximately USD 386.2 million and Q4 2025 revenue of USD 105.35 million (year-on-year growth of roughly 38%), with management guiding to continued top-line expansion in 2026.

The competitive moat rests on three reinforcing features: mission-prime status under classified and sensitive US government programmes, vertically integrated production in Colorado that compresses build cycles, and an expanding backlog of named programmes including the NITE-STAR contract and eight additional 2026 awards referenced in management commentary. Profitability, however, is the principal business-model weakness: filing-disclosed metrics show a pre-tax margin of roughly minus 25.6% in the most recent reporting period, with negative returns on equity and assets, indicating that scale and absorption, rather than pricing power, are the binding constraint on unit economics.

Financial Snapshot

Price
USD 6.60
Market Cap
USD 1.2bn
52w High
USD 44.54
52w Low
USD 7.45
Distance from 52wH
-85.2%
Avg Volume
3429241
Currency
USD

Recent Catalysts

[5 August 2026] - York Space Systems filed a Form 8-K disclosing a change in its Chief Financial Officer, with the press release attached as Exhibit 99.1. Leadership transitions at a recently listed defence prime can affect investor confidence in near-term guidance and execution credibility. Source: SEC EDGAR (Form 8-K, filing date 5 August 2026).

[22 April 2026] - ClearanceJobs reported that York's Q4 2025 revenue reached USD 105.35 million, up 38% year-on-year, and quoted the company's expectation of generating positive earnings in the period ahead. The piece framed YSS as an undervalued space stock with long-term potential. Source: ClearanceJobs, 22 April 2026.

[21 April 2026] - YSS shares were reported as up roughly 10% intraday on the New York Stock Exchange following a new contract announcement and ongoing post-earnings momentum. The same commentary noted trailing full-year revenue of about USD 386.2 million against a pre-tax margin of approximately minus 25.6%. Source: TradingView/Yahoo Finance market data feed, 21 April 2026.

[15 April 2026] - Shares extended a post-earnings rally on the day following the Q4 2025 release, with intraday gains of about 14.6% reported across market-data feeds. The move reflected investor reaction to the revenue beat and the 2026 outlook disclosed the previous day. Source: Yahoo Finance / StockAnalysis.com market data, 15 April 2026.

[4 April 2026] - Simply Wall St published a valuation note following a 19% one-day share-price move, examining whether the post-IPO price action reflected fundamentals. The commentary was descriptive of valuation rather than a confirmed corporate event. Source: Simply Wall St, 4 April 2026.

Thesis Evaluation

Bull Case (25% weight)

2026 revenue lands at or above the top end of the reduced guidance range, the Solestial integration is margin-neutral within 12 months, and at least one additional mission-prime award from the Space Development Agency is announced before mid-2027. Under those conditions the share price could re-rate toward 18.00 within twelve months, equating to roughly double the current price and reflecting backlog conversion at a credible margin.

Base Case (50% weight)

Revenue growth continues at the guided 40-50% range, margins narrow only modestly from the current negative band, and no major programme is lost. The most realistic 12-month outcome is a re-rating to 11.00, around 22% above the current USD 8.98 print, as backlog conversion is priced in but the profitability risk premium remains in place.

Bear Case (25% weight)

A second consecutive cut to 2026 guidance, a key mission-prime contract loss, or material cash burn forces a dilutive equity raise. In that scenario the share price could fall back to the 52-week low and through it, with a 12-month downside target of 5.50, approximately 39% below the current level.

Weighted conviction:Bull (25%) x 100 + Base (50%) x 62 + Bear (25%) x 10 = 59/100. OPPORTUNISTIC BUY.

Key Risks

  1. Sustained unprofitability: Company filings flag the risk of continued operating losses, with the most recent pre-tax margin near minus 25.6% and negative returns on equity and assets. Estimated probability: 50%. Impact: severe.
  2. Guidance disappointment: Management already reduced the 2026 revenue guide after Q4 2025, and a further cut would materially compress valuation and likely force a re-rating lower. Estimated probability: 35%. Impact: severe.
  3. Customer concentration: Revenue is heavily concentrated in the US Department of Defense and a small number of named programmes such as NITE-STAR, leaving the top line exposed to single-programme delays or scope changes. Estimated probability: 45%. Impact: moderate.
  4. M&A integration risk: The Solestial acquisition must be absorbed without margin dilution; execution missteps could compound the existing negative profitability profile. Estimated probability: 35%. Impact: moderate.
  5. Post-IPO volatility and dilutive financing: Recent share price has been described as a volatile post-IPO run, and a sustained cash burn path could compel a secondary offering at unfavourable levels. Estimated probability: 30%. Impact: severe.
  6. Key-person and governance transition: The 5 August 2026 8-K disclosed a change in Chief Financial Officer, which during the post-IPO period can heighten execution and disclosure risk until a permanent successor settles in. Estimated probability: 25%. Impact: moderate.

Who Should Own It / Avoid It

Ideal for: investors with a high risk tolerance and a minimum 12-18 month holding horizon who are comfortable with unprofitable, US defence-and-space exposure and who want a satellite-and-mission-prime beneficiary of the proliferated-architecture build-out. Suitable for accounts able to tolerate double-digit intra-year drawdowns, who accept a negative current earnings profile, and who are primarily looking for backlog-and-contract-momentum exposure rather than near-term cash earnings. Position sizing should reflect both the binary nature of contract outcomes and the recent CFO transition.

Avoid if: investors require current profitability, a near-term income yield, or a low-volatility profile, since the share price has moved from a 52-week high of USD 44.54 to a current USD 8.98 and remains sensitive to single programme announcements. Capital-preservation investors, those with a sub-six-month horizon, and those unable to underwrite US national-security procurement risk should not hold this name.

Recommendation

OPPORTUNISTIC BUY - 59/100. The call reflects genuine backlog and contract momentum offset by filing-disclosed profitability risk and an already-reduced 2026 revenue guide, leaving the risk-reward skewed positively but not yet conviction-high. An upgrade to a higher tier would require a clean beat of the current 2026 guide combined with explicit evidence of margin narrowing, while a downgrade would follow a second consecutive guidance cut, a named contract loss, or confirmation of a dilutive raise. At the current price of $6.60 the shares sit inside our buy zone (below $7.33): the risk/reward on the scenario set clears our 2:1 threshold today.

The probability-weighted value across our three scenarios is $11.38, 72% above the current price of $6.60 - the market has not yet priced our probability-weighted view. Levels below are derived from the scenario targets and probabilities above, not from percentage offsets to today's price.

BUY

below $7.33 - below this level the upside to the base-case target ($11.00) is at least 2x the downside to the bear case ($5.50), the minimum risk/reward we require before committing new capital.

HOLD

between $7.33 and $11.00 - the base case is not yet fully priced, so existing holders are paid to wait, but new money gets no margin of safety in this zone.

REDUCE

above $11.00 - at this level the base case is fully reflected in the price and anything beyond it is paying for a bull scenario we weight at 25%.

SELL

if A second consecutive reduction to 2026 revenue guidance, a named loss of the NITE-STAR programme or another flagship mission-prime contract, or confirmation of a dilutive equity raise to fund operations, regardless of price - the bear target of $5.50 is the backstop, not an arbitrary percentage stop.

Conviction Trend

Latest conviction: 59/100. Trend versus prior report: Initiation.

CONVBUYOPPSPECAVOID1007550250Conviction (0-100)2026-10-04
CONVICTION BUY (80+)BUY (65 - 79)OPP BUY (50 - 64)SPEC BUY (30 - 49)AVOID (0 - 29)
Report dateConviction
2026-10-0459

Sources

Market data: DYOR HQ proprietary market data workflow.

Public sentiment and news flow: Coverage drawn from public news flow including Yahoo Finance, StockAnalysis.com, TradingView, ClearanceJobs, and Simply Wall St, together with company earnings releases and NYSE-traded price action.

Primary source types: SEC filings on EDGAR (Form 8-K and related exhibits), company press releases attached as exhibits to those filings, public earnings announcements referenced by financial news wires, and third-party market-data and analyst commentary drawn from publicly available outlets.

Key sources

Analysis generated 2026-10-04. Market data as of 2026-11-12.

\n